Resources

Articles

Honrado ER, Tallo V, Balis AC, Chan GP, Cho SN. Noncompliance with the world health organization-multidrug therapy among leprosy patients in cebu, Philippines: its causes and implications on the leprosy control program. Dermatol Clin 2008; 26(2):221-229.
Copies available from Infolep.

Pardillo FE, Fajardo TT, Abalos RM, Scollard D, Gelber RH. Methods for the classification of leprosy for treatment purposes. Clin Infect Dis 2007; 44(8):1096-1099.
Copies available from Infolep.

Fajardo TT, Guinto RS, Cellona RV, Abalos RM, Dela Cruz EC, Gelber RH. A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy. Am J Trop Med Hyg 2006; 74(3):457-461.
Copies available from Infolep.

Villahermosa LG, Fajardo TT, Jr., Abalos RM, Balagon MV, Tan EV, Cellona RV et al. A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum. Am J Trop Med Hyg 2005; 72(5):518-526.
Copies available from Infolep.

Fajardo TT, Jr., Villahermosa LG, Cruz EC, Cellona RV, Balagon MV, Abalos RM et al. A clinical trial of pefloxacin and ofloxacin in lepromatous leprosy. Lepr Rev 2004; 75(4):389-397.
Download: http://www.leprosy-review.org.uk/

Villahermosa LG, Fajardo TT, Jr., Abalos RM, Cellona RV, Balagon MV, Dela Cruz EC et al. Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy. Am J Trop Med Hyg 2004; 70(2):197-200.
Copies available from Infolep.

Cellona RV, Balagon MF, Dela Cruz EC, Burgos JA, Abalos RM, Walsh GP et al. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients. Int J Lepr Other Mycobact Dis 2003; 71(4):308-319. Copies available from Infolep.